Clinical Trials Browser

NCT00001813 2026-04-22

Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy

Cockayne Syndrome, Skin Diseases, Genetic, Skin Neoplasms, Xeroderma Pigmentosum, Trichothiodystrophy Syndromes

NCT00352924 2026-04-22

Agriculture Health Study

Active not recruiting

89,655 enrolled

GenitourinaryLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT00937456 2026-04-22

Open Versus Laparoscopically-assisted Esophagectomy for Cancer

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms, Neoplasms

NCT01279096 2026-04-22

Vandevol

Phase 1 Completed

LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01851395 2026-04-22

Rapid Autopsy and Procurement of Cancer Tissue

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Thymus Neoplasms, Urogenital Neoplasms

NCT01915225 2026-04-22

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT01953900 2026-04-22

VEGAS

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

NCT02109367 2026-04-22

Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass

Ovarian Neoplasms

NCT02250755 2026-04-22

METAPERF

Phase NA Completed

Brain Neoplasms

NCT02314169 2026-04-22

Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer

Phase 2 Active not recruiting

143 enrolled 16 charts

Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

NCT02433795 2026-04-22

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

Phase 2 Completed

27 enrolled 12 charts

Lymphoma, B-Cell, Marginal Zone

NCT02555189 2026-04-22

Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression

Phase 1/2 Terminated

52 enrolled 31 charts

Prostatic Neoplasms

NCT02667574 2026-04-22

VISMONEO

Phase 2 Completed

Carcinoma, Basal Cell

NCT02874430 2026-04-22

Metformin Hydrochloride and Doxycycline in Treating Patients With Localized Breast or Uterine Cancer

Phase 2 Terminated

29 enrolled 11 charts

Breast Neoplasms

NCT02960087 2026-04-22

Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Phase NA Active not recruiting

Prostatic Neoplasms

NCT02972801 2026-04-22

Testicular Tissue Cryopreservation for Fertility Preservation

Phase NA Recruiting

Autoimmune Diseases, Infertility, Neoplasms

NCT02974647 2026-04-22

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Phase 2 Recruiting

Lymphoma, Recurrence

NCT03009240 2026-04-22

Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03038568 2026-04-22

Assessing How Normal Variations in CT Scanning Affects Its Interpretation

Active not recruiting

Gastrointestinal

Colorectal Cancer Metastatic

NCT03043872 2026-04-22

CASPIAN

Phase 3 Active not recruiting

987 enrolled 42 charts 1 FDA

Small Cell Lung Carcinoma

NCT03059173 2026-04-22

MYOPK

Phase 3 Recruiting

Polycystic Ovary Syndrome

NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

Phase 2 Completed

40 enrolled 22 charts

Gastrointestinal

Resectable Pancreatic Cancer

NCT03154996 2026-04-22

Chronic Convection Enhanced Delivery of Topotecan

Phase 1 Completed

Glioma, Recurrence

NCT03181867 2026-04-22

18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03210714 2026-04-22

Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

Phase 2 Active not recruiting

20 enrolled 10 charts

CNSGastrointestinalGenitourinaryLymphoidMyeloid

Familial ependymoma, Ependymoma, Glioma, Histiocytosis, Langerhans-Cell, Lymphoma, Non-Hodgkin, Medulloblastoma, Wilms Tumor, Neuroblastoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT03277469 2026-04-22

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

Phase NA Active not recruiting

Gynecologic Cancer

NCT03295981 2026-04-22

Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone

Phase 3 Recruiting

Giant Cell Tumor of Bone

NCT03303846 2026-04-22

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Phase NA Active not recruiting

Healthy Subject

NCT03309033 2026-04-22

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Active not recruiting

Papillomavirus Infections

NCT03395197 2026-04-22

TALAPRO-2

Phase 3 Active not recruiting

1,054 enrolled 21 charts 2 FDA

mCRPC

NCT03436654 2026-04-22

Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03481114 2026-04-22

REPAINT

Phase 2 Completed

55 enrolled 19 charts

Carcinoma, Non-Small-Cell Lung

NCT03523975 2026-04-22

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

Phase 1/2 Recruiting

Lymphoma, Mantle-Cell

NCT03563976 2026-04-22

Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer

Lung Neoplasms

NCT03625323 2026-04-22

TACTI-002

Phase 2 Completed

187 enrolled 13 charts

Squamous Cell Carcinoma of Head and Neck

NCT03736889 2026-04-22

Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

MSI-H/dMMR Solid Tumors

NCT03785288 2026-04-22

Vaginal Cuff Brachytherapy Fractionation Study

Phase 3 Recruiting

Endometrial Neoplasms

NCT03823534 2026-04-22

Post-Op Pain Control for Prophylactic Intramedullary Nailing.

Phase 3 Recruiting

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Pain, Pain, Postoperative

NCT03866382 2026-04-22

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Phase 2 Recruiting

Urachal adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Penile Neoplasms, Prostatic Neoplasms, Urethral Neoplasms, Urogenital Neoplasms

NCT03970083 2026-04-22

A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer

Active not recruiting

Uterine Cervical Neoplasms

NCT03970447 2026-04-22

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT03981146 2026-04-22

ANICCA

Phase 2 Completed

35 enrolled 15 charts

Gastrointestinal

Colorectal Neoplasms

NCT04049331 2026-04-22

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Phase 2 Active not recruiting

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

NCT04071704 2026-04-22

Assessing Health-related Quality of Life in Sarcoma Patients

Personal Satisfaction, Sarcoma

NCT04080804 2026-04-22

Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck

NCT04082520 2026-04-22

Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy

Phase 2 Recruiting

Meningioma

NCT04123366 2026-04-22

MK-7339-007

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumors

NCT04192981 2026-04-22

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

Phase 1 Active not recruiting

Brain Neoplasms, Meningeal Carcinomatosis

NCT04246177 2026-04-22

LEAP-012

Phase 3 Completed

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Hepatocellular

NCT04267848 2026-04-22

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms